CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
4.905
-0.125 (-2.48%)
Jun 2, 2026, 10:05 AM EDT - Market open
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $7.17 million as of June 2, 2026. Its market cap has increased by 4.17% in one year.
Market Cap
7.17M
Enterprise Value
4.63M
1-Year Change
4.17%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $7.17M, a decrease of -89.75%. That is a compound annual growth rate of -29.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 7.35M | 125.73% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 8.32M |
| Liminatus Pharma | 8.08M |
| PMGC Holdings | 8.04M |
| Genprex | 7.94M |
| Xenetic Biosciences | 7.58M |
| Evogene | 7.34M |
| Acurx Pharmaceuticals | 7.09M |
| Can-Fite BioPharma | 6.99M |